Eurobio Scientific Logo

Eurobio Scientific

Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.

ALERS | PA

Overview

Corporate Details

ISIN(s):
FR0004054435 (+2 more)
LEI:
969500IQEUEH806GE257
Country:
France
Address:
7 AVENUE DE SCANDINAVIE, 91940 LES ULIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eurobio Scientific is an integrated specialty diagnostics company focused on developing, manufacturing, and distributing in-vitro diagnostic (IVD) tests and life sciences products for clinical use. The company's core areas of expertise are transplantation, infectious diseases, and oncology. Its portfolio includes a range of molecular diagnostics technologies, such as prognostic genomic tests for cancer, reagents and software for transplant matching, and genetic tests for various illnesses. Eurobio Scientific serves laboratories and healthcare providers, offering both its own proprietary solutions, which constitute a significant portion of its revenue, and products from partner companies through its distribution network.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-13 18:30
Interim / Quarterly Report
EUROBIO SCIENTIFIC : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2025
French 947.6 KB
2025-09-24 17:40
Earnings Release
Eurobio Scientific : résultat du 1er semestre 2025
French 270.5 KB
2025-09-24 17:40
Earnings Release
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
English 276.5 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
French 177.0 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
English 173.7 KB
2025-06-17 16:59
Major Shareholding Notification
Franchissement de seuils
French 116.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
French 135.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific: EB Development rises above 90% threshold
English 134.8 KB
2025-04-29 21:00
Report Publication Announcement
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
French 610.9 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
French 216.3 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific: 2024 annual results
English 231.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
French 131.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
English 133.7 KB
2025-03-04 20:03
Regulatory Filings
Eurobio Scientific : résiliation du contrat de liquidité
French 134.6 KB
2025-01-15 17:46
Report Publication Announcement
Eurobio Scientific : calendrier des publications financieres 2025
French 598.6 KB

Automate Your Workflow. Get a real-time feed of all Eurobio Scientific filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurobio Scientific

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurobio Scientific via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-12-18 N/A Other Buy 1,000 15,180.00 EUR

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America
ARTL
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America
AAPG
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Developing a nano-platform for rapid, sublingual delivery of reformulated medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Offers branded prescription drugs for neurology, pain, and CNS to US patients.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan
4503
AstraZeneca PLC Logo
Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.
United Kingdom
AZN

Talk to a Data Expert

Have a question? We'll get back to you promptly.